相关实验视频

Updated: Jun 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

固体瘤中的自我瘤抗原通过α-gal Micelle免疫疗法转化为疫苗

¹Department of Medicine, Rush University Medical Center, Chicago, IL 60612, USA.

|October 26, 2024

概括

这项研究引入了用于癌症免疫治疗的α-gal细胞,通过向抗原呈现细胞来增强对瘤抗原的免疫反应. 临床试验显示安全性和T细胞透到转移.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

瘤的免疫系统逃避往往是由于抗原呈现细胞 (APC) 呈现抗原的表现不佳.
增强瘤抗原 (TA) 免疫性可以通过促进瘤细胞的APC吸收而实现,而无需事先识别TA.

研究的目的:

为了研究瘤内注射α-gal小粒来增强抗瘤免疫力的疗效.
评估这种方法作为个性化癌症疫苗和新辅助疗法的潜力.

主要方法:

在瘤细胞内注射α-gal微粒,导致抗-Gal抗体结合和补体激活.
通过补充来招募APC,随后是瘤细胞的细胞化和TA处理.
在小鼠模型中评估抗瘤效应,并在1期临床试验中评估安全性/T细胞透.

主要成果:

α-gal小粒促进瘤细胞的APC吸收,将瘤转化为个性化的TA疫苗.
治疗诱导了对小鼠远程转移的保护,并与检查点抑制剂协同作用.
第1期试验证明了安全性,并增加了CD4+和CD8+T细胞透到转移中.

结论:

α-gal micelle免疫疗法是一种安全有效的策略,可以增强抗瘤免疫反应.
这种方法既是新辅助疗法,也是产生个性化癌症疫苗的方法.
需要进一步的临床研究,以优化其在癌症治疗中的使用.

关键词:

在 AGI-134 中,AGI-134 是在APC招募人才反加尔抗体的抗体.癌症免疫疗法免疫疗法瘤抗原是一种瘤抗原.一个α-gal的表象.α-gal 葡萄糖类脂类一个α-gal微粒.这是一种α-gal疗法.

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...